Abstract
In vivo animal experiments are essential (and a regulatory requirement) to demonstrate the potential efficacy, safety and pharmacodynamic/pharmaco-kinetic profile of candidate drugs. However, the number of pharmacologists (and other bioscientists) with integrative (in vivo) pharmacology skills has been in decline for a number of years, as have the opportunities for students to learn such skills. This article reviews some recent initiatives that are underway to rebuild this essential skills base in the United Kingdom and the United States. Partnerships between industry and national funders of research and education have proved to be a particularly effective approach to support this strategically important area of biological science.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
An integrative pharmacological approach to radio telemetry and blood sampling in pharmaceutical drug discovery and safety assessment
BioMedical Engineering OnLine Open Access 18 January 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kola, I. & Landis, J. Can the pharmaceutical industry reduce attrition rates? Nature Rev. Drug Discov. 3, 711–716 (2004)
The In Vivo Pharmacology Training Group. The fall and rise of in vivo pharmacology. Trends Pharmacol. Sci. 23, 13–18 (2002)
Frantz, S. In vivo we trust. Nature Rev. Drug Discov. 2, 501 (2003)
Sustaining the skills pipeline in the pharmaceutical and biopharmaceutical industries. Report by The Association of the British Pharmaceutical Industry [online], (2005).
Leggett, M. Teaching of in vivo research techniques in UK universities — wide-ranging and prompt action is needed. Physiol. News 60, 39–40 (2005)
Jobe, P. C. et al. The essential role of integrative biomedical sciences in protecting and contributing to the wealth and well being of our nation. Pharmacologist 40, 32–37 (1998)
Falk, M. & Emenaker, N. The status and future of integrative and organ systems sciences in the United States (Executive Summary). Life Sciences Research Office [online], (2003)
Critical Path Opportunities Report. U. S. Department of Health and Human Services, Food and Drug Administration. [online] (2006)
Preusch, P. C. Integrative and organ systems pharmacology: a new initiative from the National Institute of General Medical Sciences. Mol. Interv. 4, 72–73 (2004)
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Related links
Rights and permissions
About this article
Cite this article
Collis, M. Integrative pharmacology and drug discovery — is the tide finally turning?. Nat Rev Drug Discov 5, 377–380 (2006). https://doi.org/10.1038/nrd2036
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd2036
This article is cited by
-
An integrative pharmacological approach to radio telemetry and blood sampling in pharmaceutical drug discovery and safety assessment
BioMedical Engineering OnLine (2011)
